Company Overview - STERIS plc, based in Mentor, Ohio, specializes in infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services, founded in 1985 [1] - The company's current market capitalization is $24.5 billion, with the Q3 2026 earnings report expected to be released soon [1] Earnings Expectations - Analysts predict STERIS will generate earnings of $2.53 per share for Q3 2026, reflecting a 9.1% increase from $2.32 per share in the same quarter last year [2] - For fiscal 2025, the expected EPS is $10.23, indicating an 11% increase from $9.22 reported in fiscal 2024, with further growth anticipated to $11.11 in fiscal 2027, an 8.6% year-over-year increase [3] Stock Performance - Over the past 52 weeks, STERIS shares have increased by 25.5%, outperforming the S&P 500 Index's 17.1% rise and the State Street Health Care Select Sector SPDR ETF's 14.3% return [4] - Following the release of its Q2 2026 earnings, STERIS shares closed up by 6.9%, with quarterly revenue reported at $1.5 billion, exceeding Wall Street estimates, and an adjusted EPS of $2.47 also surpassing projections [5] Analyst Ratings - The consensus view among analysts is moderately bullish, with a "Moderate Buy" rating overall; six out of nine analysts recommend a "Strong Buy," while three suggest a "Hold" [6] - The mean price target for STERIS is $288.86, indicating an 11.4% potential upside from current price levels [6]

Company Overview - UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products [4] - The company plays a significant role in the medical device supply chain and serves as a valued outsourcing partner to many leading medical device manufacturers globally [4] - UFP's products include single-use and single-patient devices and components used in various medical applications such as minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants [4] Event Participation - UFP Technologies will present at the East Coast IDEAS Investor Conference on June 11, 2025, at The Westin Times Square in New York, NY [1] - The presentation will be led by Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, starting at 7:55 AM ET [1] - The presentation will be available via webcast on the conference host's website and UFP's investor relations section [1] Conference Information - The IDEAS Investor Conferences aim to provide independent venues for quality companies to present their investment merits to investment professionals [2] - The conferences are sponsored by investors for the benefit of regional investment communities, with sponsors managing over $200 billion in assets [2] - The events are produced annually by Three Part Advisors, LLC, with additional information available on their website [3]